Global E-cigarette Market Weekly (1.15-1.21)

Industry Insight by 2FIRSTS
Jan.22.2024
Global E-cigarette Market Weekly (1.15-1.21)
In a challenging market, big cigarette brands are entering Japan, while Malaysia pushes for e-liquid regulation. Can Korea's e-cigarette market rise in 2024?

The "credit society" with airtight regulations, stringent production conditions, and advertisers who constantly switch channels make it challenging for new tobacco brands to enter the Japanese market. However, as small brands face entry barriers and believe in the vast market potential after the relaxation of zero nicotine restrictions, established brands have started to seize this opportunity and expand their distribution.

 

The Malaysian E-Cigarette Consumers Association has announced that they have shared the findings of the 2FIRSTS report with local consumers and will continue to advocate for local e-liquid regulations.

 

In 2023, multiple well-known disposable e-cigarette brands such as ELFBAR and VUSE have entered the South Korean market. Simultaneously, South Korean conglomerates are also actively establishing their presence in the e-cigarette industry. This series of developments has the potential to disrupt the existing landscape of the South Korean e-cigarette market. In light of these changes, the question arises: Can the South Korean e-cigarette market thrive in 2024?

 

On January 18th, a backbench debate took place in the British Parliament, allowing backbench MPs to raise local or national issues and receive responses from relevant government ministers. The debate focused on the regulation of e-cigarettes in the UK, the World Health Organization (WHO), and the contrasting views between the organization and the British government regarding e-cigarettes.

 

On January 18, 2024, 2FIRSTS and CNR News held a signing ceremony for the ESG projects in the vaping industry, accompanied by the release of the "2023 Global Vaping Industry ESG Development Report" at the CNR News headquarters in Beijing. The event was attended by Wu Gang, Deputy Editor-in-Chief of CNR News, Zhao Tong, Co-founder and CEO of 2FIRSTS, Hu Lishan, Senior Director of the Financial and Economic Department at CNR News, and Hou Yuhuan, Global Vice President and Executive Editor-in-Chief of 2FIRSTS.

 

Blu's former factory, Tianchang Group, experiences a 79% decrease in e-cigarette sales and plans to seek new customers to expand its customer base.

 

The U.S. Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) to SMOK, a manufacturer of 22 e-cigarette products. Please refer to the detailed list at the end of the article.

 

Guangdong Liwang New Energy Co., Ltd. received three institutional visits and highlighted its advantages and future plans in the lithium-ion battery business.

 

Vuse Go 800 is set to be widely available in South Korea, with distribution expanding to include 30,000 convenience stores and tobacco shops throughout the country.

 

SKE, a company specializing in electronic atomizer components, has announced its plan to establish an industrial park in Guangshui City, Hubei Province, with a total investment of 1 billion RMB.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Russia Adds Vapes to “Strategic Goods” List, Illegal Cross-Border Trade Faces Up to Five Years in Prison
Russia Adds Vapes to “Strategic Goods” List, Illegal Cross-Border Trade Faces Up to Five Years in Prison
Russia will place e-cigarettes and related nicotine products under its “strategic goods” framework from August 20, 2026. According to TVP World’s report published on August 19, the newly listed items include e-cigarettes, electronic smoking devices, vape liquids and nicotine salts. Individuals who illegally move these products across Russia’s customs border or its state border with other Eurasian Economic Union (EAEU) members could face up to five years in prison if shipment values exceed 100,000 rubles (about €1,000), provided all elements of a criminal offence are established.
Aug.20
Product | PMI Pilots bonds by IQOS and blends in Japan, Testing a New Heated Tobacco Platform
Product | PMI Pilots bonds by IQOS and blends in Japan, Testing a New Heated Tobacco Platform
Philip Morris International (PMI) has launched a regional pilot of bonds by IQOS and dedicated blends tobacco sticks in Japan, introducing a new heated tobacco platform separate from the IQOS ILUMA ecosystem. The system uses Round Heat Technology with an external heating architecture, differentiating it from IQOS ILUMA’s induction-based platform. The pilot began on July 6, 2026, across three Japanese prefectures: Fukuoka, Saga and Nagasaki.
Jul.30
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28